HBSP (USA)
-
Arcadia Biosciences: Seeds of Change (Abridged)
Daemmrich, Arthur A.Case HBS-711050-EArcadia Biosciences is seeking to introduce genetically modified rice to China that will lower farmers' costs and generate environmental benefits through reduced greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology company, notably uneven enforcement of intellectual property in emerging market countries, and uncertainty regarding the provision and market value of carbon credits under international c...Starting at €8.20
-
IED en China
Huang, YashengCase HBS-706S22EconomicsChina es uno de los destinos de inversión populares en el mundo. A lo largo de gran parte de la década de 1990, China representó el 50% de la inversión extranjera directa (IED) de entrar en los países en desarrollo, y entre 1994 y 1997, China fue el segundo mayor receptor de IED en el mundo, después de Estados Unidos. Los recientes acuerdos entre China y Estados Unidos y la Unión Europea sobre la adhesión de China a la Organización Mundial del Co...Starting at €8.20
-
Arcadia Biosciences: Seeds of Change
Daemmrich, Arthur A.; Reinhardt, Forest L.; Shelman, MaryCase HBS-709019-EArcadia Biosciences is an entrepreneurial California agricultural biotech company seeking to earn carbon credits by modifying commodity crops for use in China and India. Eric Rey, Arcadia's CEO, faced a strategic inflection point in early September, 2008. The company had a plan to share carbon credits allocated by the United Nations Clean Development Mechanism Executive Board to China, for use of Arcadia's rice varieties, since they enabled farme...Starting at €8.20